ABOS stock news
This page provides real-time market news, earnings updates, and company announcements related to Acumen Pharmaceuticals, Inc. (ABOS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 09:17 EST
Castellum, Inc. Pays Off All Debt
Finviz2026-02-17 11:48:08
YETI Announces CFO Transition
Finviz2026-02-19 11:03:47
Advantage Solutions Appoints Thomas Turner and Frank Yao to Board of Directors
Finviz2026-02-25 13:03:48
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer
Finviz2026-03-02 12:03:46
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
Finviz2026-03-10 20:03:45
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Orion Group Holdings, Inc. Announces Retirement of Two Board Members and Decrease in Board Size
Finviz2026-03-17 20:09:45
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Finviz2026-03-17 20:09:45
ECARX Strengthens Global Leadership Team with Appointment of Dylan D. Jeng as Chief Financial Officer
Finviz2026-03-23 11:04:14
Simon Property Group Announces the Passing of David Simon
Finviz2026-03-23 12:51:53
17 Education & Technology Group Inc. Announces Appointment of Chief Financial Officer
Finviz2026-03-24 10:03:54
Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer
Finviz2026-03-24 11:33:39
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
Finviz2026-03-26 11:03:08
Acumen Pharmaceuticals, Inc. (Acumen Pharmaceuticals) recently officially released its annual financial report for the year ended December 31, 2025, and simultaneously reviewed the key business developments of the company over the past year.
老虎证券2026-03-26 11:26:03
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Acumen Pharmaceuticals has officially registered a public offering plan of common stock initiated by selling shareholders.
老虎证券2026-03-26 20:36:02
Steel Dynamics Thanks Richard P. Teets, Jr. and Gabriel L. Shaheen for their Exemplary Board Service
Finviz2026-03-27 14:03:46
Dycom Industries, Inc. Appoints Company Veteran Bo Gresham as its First Chief Revenue Officer to Lead Next Phase of Growth
Finviz2026-03-31 20:51:49
Elauwit Connection Appoints James Di Bartolo as Chief Financial Officer
Finviz2026-04-01 11:33:06
Landstar General Counsel to Join Scopelitis Law Firm Names Assistant General Counsel as Interim General Counsel
Finviz2026-04-02 13:03:07
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
Finviz2026-04-07 11:33:11
LightPath Appoints Two Senior Sales Executives to Drive Defense and Commercial Growth
Finviz2026-04-08 12:33:07
AEP Names Maryam S. Brown President and COO of Indiana Michigan Power
Finviz2026-04-13 15:03:44
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
Finviz2026-03-10 20:03:45
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Orion Group Holdings, Inc. Announces Retirement of Two Board Members and Decrease in Board Size
Finviz2026-03-17 20:09:45
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Finviz2026-03-17 20:09:45
ECARX Strengthens Global Leadership Team with Appointment of Dylan D. Jeng as Chief Financial Officer
Finviz2026-03-23 11:04:14
Simon Property Group Announces the Passing of David Simon
Finviz2026-03-23 12:51:53
17 Education & Technology Group Inc. Announces Appointment of Chief Financial Officer
Finviz2026-03-24 10:03:54
Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer
Finviz2026-03-24 11:33:39
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
Finviz2026-03-26 11:03:08
Acumen Pharmaceuticals, Inc. (Acumen Pharmaceuticals) recently officially released its annual financial report for the year ended December 31, 2025, and simultaneously reviewed the key business developments of the company over the past year.
老虎证券2026-03-26 11:26:03
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Acumen Pharmaceuticals has officially registered a public offering plan of common stock initiated by selling shareholders.
老虎证券2026-03-26 20:36:02
Steel Dynamics Thanks Richard P. Teets, Jr. and Gabriel L. Shaheen for their Exemplary Board Service
Finviz2026-03-27 14:03:46
Dycom Industries, Inc. Appoints Company Veteran Bo Gresham as its First Chief Revenue Officer to Lead Next Phase of Growth
Finviz2026-03-31 20:51:49
Elauwit Connection Appoints James Di Bartolo as Chief Financial Officer
Finviz2026-04-01 11:33:06
Landstar General Counsel to Join Scopelitis Law Firm Names Assistant General Counsel as Interim General Counsel
Finviz2026-04-02 13:03:07
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
Finviz2026-04-07 11:33:11
LightPath Appoints Two Senior Sales Executives to Drive Defense and Commercial Growth
Finviz2026-04-08 12:33:07
AEP Names Maryam S. Brown President and COO of Indiana Michigan Power
Finviz2026-04-13 15:03:44
ABOS stock chart
ABOS stock detailsABOS stock price change
On the last trading day, ABOS stock closed at 2.72 USD, with a price change of 1.49% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more